Rimed was established in 1982. Since then the company has been developing manufacturing and exporting 7 generations of non-invasive Vascular & Transcranial Doppler systems.
Rimed introduced into the market the first PC-based peripheral Vascular Doppler and was also the first to introduce the customizable “summary screen” concept which has since been adopted by other companies.
The company now offers a new line of digital transcranial Dopplers with M-Mode as well as an integrated carotid imaging probe.
With over 5,000 installations worldwide, mainly in neurology departments and stroke units, Rimed has become a reputable brand name in the field of transcranial Doppler (TCD) technology.
Rimed’s line of products carry all international certificates: CE, ISO 13485:2003, FDA, CFDA and more.
Rimed’s long standing expertise, knowhow and financial stability, over past 3 decades, has made it the dynamic and innovative company it has become, developing advanced diagnostic tools at the forefront of medical technology.
Transcranial Doppler uses a handheld-pulsed low frequency Doppler transducer that enables recording of blood flow velocities from intracranial arteries through selected cranial foramina and thin regions of the skull. Analysis of the Doppler spectra allows display and calculation of peak systolic, peak diastolic, and mean velocities and pulsatility indices. Mapping of the sampled velocities as a color display of spectra in lateral, coronal and horizontal views locates the major brain arteries in three dimensions.
Transcranial Doppler (TCD) Advantages
Non-invasive method enabling physicians to define moment-to-moment changes in cerebral blood flow velocities.
Bedside assessment of cerebrovascular circulation hemodynamics.
Continuous monitoring for emboli detection.
Intra-operative and post-operative monitoring for identifying hypoperfusion, preoperative thrombosis, heperperfusion syndrome and ongoing intra-arterial embolism.
Absolutely safe. Contrast agents are not used, thereby avoiding allergic reactions and decreasing risk to the patient.